China's LEAPER RNA Editing Platform Achieves First Clinical Milestone in Duchenne Muscular Dystrophy | Resposta

China's LEAPER RNA Editing Platform Achieves First Clinical Milestone in Duchenne Muscular Dystrophy | Resposta | Studio Global AI